ANTIPODES PARTNERS Ltd: META position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on META, newest first. How the timeline and the estimate are built.
ANTIPODES PARTNERS Ltd held 181,943 META shares at 2026-06-30 per its 13F-HR filed 2026-08-06.
the latest 13F is the newest step
- period ended2026-06-3013F 181,943 sharesChange vs previous 13F +85,677 shares
1.88% of the 13F portfolio, value $102,486,672.
13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 96,266 sharesChange vs previous 13F -82,977 shares
1.06% of the 13F portfolio, value $55,076,667.
13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 179,243 sharesChange vs previous 13F +179,243 shares
2.48% of the 13F portfolio, value $118,325,383.
13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 0 sharesChange vs previous 13F -148,322 shares
13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-09-3013F 148,322 sharesChange vs previous 13F not available
2.94% of the 13F portfolio, value $84,911,565.
13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).